Cargando…

Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).

Ninety-seven cases of chronic myelomonocytic leukaemia (CMML) were examined retrospectively for survival and possible prognostic factors including age, total white cell count, peripheral blood and bone marrow monocyte counts, % double esterase (DE) positive cells in bone marrow and serum lysozyme. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stark, A. N., Thorogood, J., Head, C., Roberts, B. E., Scott, C. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001685/ https://www.ncbi.nlm.nih.gov/pubmed/3476144

Ejemplares similares

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
por: Valent, Peter, et al.
Publicado: (2019)

Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center
por: Wang, Chao, et al.
Publicado: (2022)

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
por: Laborde, R R, et al.
Publicado: (2013)

Chronic myelomonocytic leukemia (CMML)-0 with pleural effusion as first manifestation: A case report
por: Hu, Lianbo, et al.
Publicado: (2020)

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2021)

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
por: Bezerra, Evandro D., et al.
Publicado: (2021)

A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
por: Elli, Elena, et al.
Publicado: (2012)

Efficient Induction of Extrinsic Cell Death by Dandelion Root Extract in Human Chronic Myelomonocytic Leukemia (CMML) Cells
por: Ovadje, Pamela, et al.
Publicado: (2012)

A Case of Synchronous Bone Marrow Chronic Myelomonocytic Leukemia (CMML) and Nodal Marginal Zone Lymphoma (NMZL)
por: Soriano, Paolo K., et al.
Publicado: (2018)

Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
por: Savona, Michael R., et al.
Publicado: (2020)

Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by Next Generation Sequencing
por: Rechsteiner, Markus, et al.
Publicado: (2014)

P727: REFINING RISK STRATIFICATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): A COMPREHENSIVE ASSESSMENT OF THE IPSS-M AND OTHER MOLECULARLY INTEGRATED PROGNOSTIC MODELS
por: Aguirre, Luis E., et al.
Publicado: (2023)

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
Publicado: (2022)

Tracking chronic myelomonocytic leukaemia diversity at the single cell level
por: Solary, Eric
Publicado: (2020)

Mouse Models of CMML
por: Belotserkovskaya, Ekaterina, et al.
Publicado: (2021)

Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature: Acknowledgments
por: Qiao, Yanhong, et al.
Publicado: (2020)

A case of mandibular osteomyelitis in a patient with chronic myelomonocytic leukaemia
por: Kojima, Yuki, et al.
Publicado: (2016)

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia
por: Machherndl‐Spandl, Sigrid, et al.
Publicado: (2021)

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum
por: Calvo, Xavier, et al.
Publicado: (2022)

A Case of Acquired Haemophilia A in a Patient with Chronic Myelomonocytic Leukaemia
por: Araki, Takeshi, et al.
Publicado: (2019)

Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome
por: Wiseman, Daniel H, et al.
Publicado: (2020)

The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia
por: Murali, Aarya, et al.
Publicado: (2021)

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
por: Palomo, Laura, et al.
Publicado: (2019)

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
por: Merlevede, Jane, et al.
Publicado: (2016)

Malignant myelomonocytic cells after in vitro infection of marrow cells with Friend leukaemia virus.
por: Testa, N. G., et al.
Publicado: (1980)

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)

Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders
por: Dussiau, Charles, et al.
Publicado: (2023)

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
por: Padron, E, et al.
Publicado: (2015)

Rapidly developing renal milk of calcium in a patient with myelomonocytic leukaemia
por: Morjaria, Anika, et al.
Publicado: (2014)

Comparison of existing prognostic models in chronic myelomonocytic leukemia
por: Jian, Jin-Li, et al.
Publicado: (2020)

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
por: Dinardo, Courtney, et al.
Publicado: (2023)

P720: A BONE MARROW MICROENVIRONMENTAL CELL SIGNATURE SCORING SYSTEM INDEPENDENTLY PREDICTED SURVIVAL AND DRUG RESISTANCE IN CHRONIC MYELOMONOCYTIC LEUKAEMIA PATIENTS
por: Wang, Yu-Hung, et al.
Publicado: (2023)

P726: TET2 ALLELIC BURDEN IMPRINTS A CONTEXT-DEPENDENT PROGNOSTIC SIGNIFICANCE OF ASXL1 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
por: Wang, Yu-Hung, et al.
Publicado: (2023)

Transformation of CMML to AML presenting with acute kidney injury
por: DeBoer, Rebecca, et al.
Publicado: (2020)

Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13,+15 double trisomy resulting in an adverse outcome
por: McGrattan, Peter, et al.
Publicado: (2007)

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
por: Patnaik, M M, et al.
Publicado: (2015)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
por: Patnaik, M M, et al.
Publicado: (2015)

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia
por: Huemer, Florian, et al.
Publicado: (2018)

Lysozyme nephropathy in chronic myelomonocytic leukemia
por: Patel, Ami B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oi5oau453i8sa0sob6a6m0j84r